# M13 Batch 52 — consolidated review reconciliation and Batch 53 handoff

Date: 2026-11-12  
Branch: `m13-system-wide-depth-audit-2026-10-09`  
Frozen selection revision: `1289e3cf216be6f68fd16c992a33ad36c319cc44`  
Queue workflow run: `43195527152`  
Queue artifact: `13932662093`  
Scope: 100 Claims across five non-overlapping lanes of 20.

## 1. Batch completion status

- Lane 1: 20/20 reviewed — `M13-BATCH-52-LANE-01-SOURCE-PASSAGE-REVIEW-2026-11-12.md`
- Lane 2: 20/20 reviewed — `M13-BATCH-52-LANE-02-SOURCE-PASSAGE-REVIEW-2026-11-12.md`
- Lane 3: 20/20 reviewed — `M13-BATCH-52-LANE-03-SOURCE-PASSAGE-REVIEW-2026-11-12.md`
- Lane 4: 20/20 reviewed — `M13-BATCH-52-LANE-04-SOURCE-PASSAGE-REVIEW-2026-11-12.md`
- Lane 5: 20/20 reviewed — `M13-BATCH-52-LANE-05-SOURCE-PASSAGE-REVIEW-2026-11-12.md`

**Desk-review coverage: 100/100.** The five lane files contain one scored row per selected Claim. The frozen queue selection is the denominator for this batch. No Claim, Evidence Use or Source JSON was edited.

This is a completed first-pass desk review and reconciliation, **not** acceptance, independent peer review, specialist sign-off, Human View clearance, or release clearance. Every Claim remains HOLD until its open evidence and review requirements are resolved.

## 2. D/E/B reconciliation

The lane reports were reconciled row by row. Distribution across the 100 selected Claims:

| Dimension | Score 0 | Score 1 | Score 2 | Score 3 | Total points | Mean |
|---|---:|---:|---:|---:|---:|---:|
| D — directness/claim fit | 0 | 5 | 58 | 37 | 232 | 2.32 |
| E — evidence-use precision | 1 | 92 | 7 | 0 | 106 | 1.06 |
| B — breadth/independence | 0 | 10 | 85 | 5 | 195 | 1.95 |

These are provisional **model-assisted desk assessments** under the M13 rubric. They are not human reviewer scores and must not be presented as independent or specialist judgements. The score distributions do not authorize canonical record changes.

### Interpretation

1. **The dominant systemic weakness is Evidence Use precision.** 92/100 Claims score E=1, seven score E=2, and one scores E=0. No Claim reaches E=3. Most Evidence Use records do not preserve a reproducible claim-specific section/page/table/figure locator.
2. **Direct source fit is often stronger than the recorded Evidence Use.** Many Claims have an authoritative source passage that appears to support the proposition, but the repository record does not identify the passage precisely enough for another reviewer to reproduce the assessment.
3. **One clear mismatch requires correction or reclassification:** `CLM-INFORMATION_ETHICS_BASICS-C@1` is an epistemic reliability/evidential-value proposition linked to an IFLA librarians' ethics code that does not establish that proposition (E=0).
4. **Other recurring gaps:** inaccessible or broad topic URLs; archived or draft source editions; source passages supporting only part of a Claim; claims that generalize from one jurisdiction or case; and claims whose Evidence Use text asserts support without naming the passage.
5. **All 100 remain HOLD.** The D/B scores do not override E gaps, high-consequence controls, source-version/rights checks, or independent review requirements.

## 3. Risk and queue-quality reconciliation

The frozen automation queue contains 100 rows, but every row has:
- `risk_domains` empty;
- `machine_triage_flags` empty;
- `structural_finding_priority = 0`.

Therefore, the queue cannot establish that any selected Claim is or is not high-consequence. Risk classification was not supplied by the queue and must not be inferred from empty fields.

A clear high-consequence case surfaced during the desk review: `CLM-FLOOD-FOOD-FDA-CONTACT@1`. FDA guidance directly supports the main food-contact rule and its narrow salvage exceptions for undamaged commercially prepared all-metal cans and retort pouches, but this Claim remains HOLD pending exact pinpoint, independent food-safety review, Human View and editorial/rights checks. The corpus-wide risk overlay remains open; this is not a statement that this is the only high-consequence Claim in the batch or corpus.

## 4. Automation boundary and measurement

The queue artifact's own metadata states:
- source text fetched: false;
- scores assigned: false;
- canonical records modified: false;
- machine runtime: 4.261 seconds;
- human review time measured: false;
- manual baseline available: false;
- speedup claim authorized: false.

This is correct and must be preserved. The automation assembled a review queue and repository-local evidence packets; it did not verify external source passages, assign D/E/B, or edit canonical records. The later lane reviews used public page content and authoritative indexed source material; some pages were inaccessible or only partially available. Exact source locators still need to be captured in versioned Evidence Use records through controlled changes.

No productivity or speedup claim is authorized.

## 5. Cross-lane findings requiring follow-up

### A. Evidence Use locator debt
For each Claim, create a reproducible chain from exact Claim version to exact Evidence Use version to exact Source edition and pinpoint. A source URL alone, a topic landing page, or a generic Evidence Use description is insufficient.

### B. Source identity/version problems
Reconcile inaccessible/broad IEA, EIA, World Bank and CDC links; archived Stanford game-theory content; draft IISE material; older NIST pages; and the applicable NASA directive revision. Alternative sources identified in lane reports are candidates, not silently accepted replacements.

### C. Claim/source mismatch and scope
- `CLM-INFORMATION_ETHICS_BASICS-C@1`: source mismatch; find a source about information reliability/evidential value or reclassify the Claim.
- `CLM-HUMAN_COMPUTER_INTERACTION_BASICS-A@1`: current NIST Evidence Use is only conceptually related, not direct support.
- `CLM-INDUSTRIAL_ENGINEERING_BASICS-C@1`: integrated-system definition does not by itself establish the stronger component-optimization/system-interaction proposition.
- `CLM-INSURANCE_BASICS-C@1`: OECD insurance overview does not establish specific policy exclusions/coverage terms.
- `CLM-LABOR_ECONOMICS_BASICS-B@1`: wage-as-worker-income is better supported than the employer-cost component.
- `CLM-MAPS_AND_NAVIGATION_BASICS-C@1`: map scale/topography support does not establish currentness and field-condition limitations.
- `CLM-GRAPH_THEORY_BASICS-B@1`: MIT Chapter 5 supports undirected graphs; the directed-graph half requires Chapter 6 or another direct source.
- Formal-methods, geophysics and materials-science Claims have specific passage gaps recorded in the relevant lane files.

### D. High-consequence and specialist controls
Do not lower HOLD based only on general source fit. FDA food-safety guidance, and any other Claim identified by the separate risk overlay, must receive appropriate independent specialist review and Human View before acceptance.

## 6. Canonical record and repository integrity

- Canonical Claim/Evidence Use/Source JSON changed: 0.
- No source substitution or ID normalization was performed.
- All review outputs are append-only audit/release documentation on the M13 working branch.
- PR #21 remains Draft/unmerged.
- `main` was not modified.
- No merge or release clearance is implied.

## 7. Batch 53 handoff

Batch 52's five desk-review lanes are complete. Before Batch 53 begins:

1. Refresh the queue from the **current M13 branch HEAD**, not the frozen Batch 52 revision.
2. Ensure the next selection is a non-overlapping 100-Claim set and reconcile it against the full denominator and all prior batch dispositions.
3. Populate risk-domain/high-consequence triage fields or explicitly report why they are unavailable; blank risk fields must never be interpreted as low risk.
4. Keep automation limited to inventory, deterministic linkage checks and worklist assembly. External source text, exact pinpoints and D/E/B remain review tasks.
5. Continue with five non-overlapping lanes of 20, preserving explicit HOLD where source passage, scope, version, independence or reviewer requirements are unresolved.
6. Do not edit canonical records without bounded authorization and regression coverage. Do not run full CI after every small edit; run the appropriate checks at the completed batch/reconciliation milestone.
7. Do not merge PR #21 or change `main` until the agreed release gates and exact-head checks are satisfied.

**Batch 52 status: desk-review coverage complete (100/100); acceptance/release gates remain open. Batch 53 selection is pending a refreshed queue generated from the current branch head.**
